Market by Phase Type, Service, Sponsor, and Country Outlook | Forecast 2022-2028
As per Triton’s report, the clinical trials support services market in the Asia-Pacific is likely to advance with a CAGR of 8.41% in the estimated period from 2022 to 2028.
Report scope can be customized per your requirements. Request For Customization
The countries scrutinized in this region
include:
• South Korea
• ASEAN Countries
• India
• Japan
• Australia & New
Zealand
• China
• Rest of Asia-Pacific
China accounted for the largest share of the
Asia-Pacific market in 2021.
The high prevalence of certain diseases in some Asian countries makes them
preferred sites for the treatment trials of those diseases. Pharmaceutical
companies, for instance, are more likely to conduct drug trials for treating
gastroesophageal cancer or liver cancer in China or Korea, respectively,
because these nations have a large pool of patients affected by these ailments.
China provides lucrative opportunities for conducting clinical trials,
owing to its vast population. Owing to this, there are a number of research
experts and other professionals required to efficiently conduct trials
available, along with a large patient pool. Moreover, government regulations
are also favorable, which aids in conducting clinical trials. China is now
focusing on increasing the number of clinical trials conducted each year. These
factors are indicative of the clinical trials support services market’s growth
in the country, over the coming years.
South Korea has emerged as an attractive destination for conducting
clinical trials owing to the availability of clinical experts, a robust
infrastructure, a dense population, favorable government regulations, etc. The
nation has an added advantage along with access to a larger population, i.e.,
its aging population is higher than its young population. Another advantage is
the similar disease patterns and unmet medical needs of the Korean population
compared to those in western countries. All these advantages attract
pharmaceutical companies and other organizations in this field to conduct their
clinical trials in the country, thus bolstering the market’s growth.
Some of the data management activities include data collection; data
entry & validation; case report form (CRF) design, annotation, &
tracking; data storage & privacy, database designing, building, &
testing; and others. There are several solutions available for clinical trial
data management. Some of the examples of these solutions include the EXPERT
Platform by ERT, which offers clinical trial management software consisting of
data management & security and compliance monitoring services.
Triton’s report assesses the market based on
service, sponsor, and phase type. Here, the service segment comprises data management, administrative
services, clinical trial site management, regulatory services, patient
recruitment management, and other services.
The notable companies in the clinical trials
support services market are Advanced Clinical, Clinipace, ICON Plc, Labcorp
Drug Development, Charles River Laboratories, CTI Clinical Trial and Consulting
Services Inc, and WuXi AppTec.
Wuxi AppTec is a leading company that offers a wide portfolio of R&D
and manufacturing services for the pharmaceutical and healthcare industries. It
provides integrated end-to-end services through its unique business models,
which include preclinical testing & clinical research services, biology
discovery, chemistry drug CRDMO (Contract Research, Development and
Manufacturing Organization), cell & gene therapies CTDMO (Contract Testing,
Development and Manufacturing Organization), and helping customers improve the
productivity of healthcare products via cost-effective & efficient
solutions. Founded in 2000, Wuxi AppTec is headquartered in Shanghai, China.
Key deliverables of the report:
● Market CAGR during the forecasting years 2022-2028
● Detailed data highlighting key insights, industry components, and market strategies
● Comprehensive information and estimation of the clinical trials support services market revenue growth in Asia-Pacific and its influence on the parent market
● In-depth study of forthcoming trends in consumer behavioral patterns
● A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces Model
●
A wide-ranging study of factors that will challenge the
Asia-Pacific clinical trials support services market’s growth during the
upcoming years
Want to get specific insights? Our team of analysts can customize this
report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. ASIA-PACIFIC
CLINICAL TRIALS SUPPORT SERVICES MARKET
– SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE CLINICAL TRIALS SUPPORT SERVICES MARKET
2.2. KEY
INSIGHTS
2.2.1. KEY
PLAYERS’ PROMISING COLLABORATIONS
2.2.2. INCREASE
IN SCREENING TESTS
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. KEY
BUYING IMPACT ANALYSIS
2.4.1. PERFORMANCE
2.4.2. EASE
OF USE
2.4.3. SECURITY
2.4.4. COST
EFFECTIVENESS
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. INDUSTRY
COMPONENTS
2.8. REGULATORY
FRAMEWORK
2.9. KEY
MARKET STRATEGIES
2.9.1. ACQUISITIONS
2.9.2. PRODUCT
LAUNCHES
2.9.3. CONTRACTS
& AGREEMENTS
2.9.4. INVESTMENTS
& EXPANSIONS
2.10. MARKET
DRIVERS
2.10.1. NEED
TO OVERCOME THE BARRIERS IN CLINICAL TRIALS
2.10.2. RISE
IN TRIALS DUE TO INCREASED DISEASE INCIDENCE
2.11. MARKET
CHALLENGES
2.11.1. DELAYED
APPROVAL DUE TO STRINGENT REGULATORY FRAMEWORK
2.11.2. USE OF
OPEN-SOURCE SOFTWARE
2.12. MARKET
OPPORTUNITIES
2.12.1. INCREASING
DEMAND FOR VACCINES AND PHARMACEUTICALS
2.12.2. DATA
MANAGEMENT SERVICE EXPECTED TO WITNESS NOTABLE GROWTH
2.12.3. ACQUISITIONS
IN THE CLINICAL TRIALS SUPPORT SERVICES MARKET
3. ASIA-PACIFIC
CLINICAL TRIALS SUPPORT SERVICES MARKET
OUTLOOK – BY PHASE TYPE
3.1. PHASE
I
3.2. PHASE
II
3.3. PHASE
III
3.4. PHASE
IV
4. ASIA-PACIFIC
CLINICAL TRIALS SUPPORT SERVICES MARKET
OUTLOOK – BY SERVICE
4.1. CLINICAL
TRIAL SITE MANAGEMENT
4.2. ADMINISTRATIVE
SERVICES
4.3. PATIENT
RECRUITMENT MANAGEMENT
4.4. REGULATORY
SERVICES
4.5. DATA MANAGEMENT
4.6. OTHER
SERVICES
5. ASIA-PACIFIC
CLINICAL TRIALS SUPPORT SERVICES MARKET
OUTLOOK – BY SPONSOR
5.1. PHARMACEUTICAL
& BIOPHARMACEUTICAL COMPANIES
5.2. MEDICAL
DEVICE COMPANIES
5.3. OTHER
SPONSORS
6. ASIA-PACIFIC
CLINICAL TRIALS SUPPORT SERVICES MARKET
– COUNTRY OUTLOOK
6.1. CHINA
6.2. JAPAN
6.3. INDIA
6.4. SOUTH
KOREA
6.5. ASEAN
COUNTRIES
6.6. AUSTRALIA
& NEW ZEALAND
6.7. REST
OF ASIA-PACIFIC
7. COMPETITIVE
LANDSCAPE
7.1. IQVIA
7.2. PAREXEL
7.3. ICON
PLC
7.4. SYNEOS
HEALTH
7.5. LABCORP
DRUG DEVELOPMENT
7.6. CLINIPACE
7.7. KCR
7.8. CHARLES
RIVER LABORATORIES
7.9. MEDPACE
7.10. ALCURA
7.11. PSI
CRO
7.12. WORLDWIDE
CLINICAL TRIALS
7.13. CTI
CLINICAL TRIAL AND CONSULTING SERVICES INC
7.14. WUXI
APPTEC
7.15. ADVANCED
CLINICAL
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: ASIA-PACIFIC CLINICAL
TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: LIST OF
COLLABORATIONS
TABLE 3: VENDOR SCORECARD
TABLE 4: REGULATORY FRAMEWORK
TABLE 5: LIST OF ACQUISITIONS
TABLE 6: LIST OF PRODUCT
LAUNCHES
TABLE 7: LIST OF CONTRACTS
& AGREEMENTS
TABLE 8: LIST OF INVESTMENTS
& BUSINESS EXPANSIONS
TABLE 9: LIST OF PANDEMIC
OUTBREAKS
TABLE 10: LIST OF OPEN-SOURCE
SOFTWARE
TABLE 11: LAUNCH OF MEDICAL
DRUGS
TABLE 12: PROMISING
ACQUISITIONS IN THE MARKET
TABLE 13: ASIA-PACIFIC
CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)
TABLE 14: ASIA-PACIFIC
CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $
MILLION)
TABLE 15: ASIA-PACIFIC
CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)
TABLE 16: ASIA-PACIFIC
CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $
MILLION)
FIGURE
1: KEY BUYING IMPACT ANALYSIS
FIGURE
2: MARKET ATTRACTIVENESS INDEX
FIGURE
3: INDUSTRY COMPONENTS
FIGURE
4: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2021
& 2028 (IN %)
FIGURE
5: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE I, 2022-2028
(IN $ MILLION)
FIGURE
6: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE II, 2022-2028
(IN $ MILLION)
FIGURE
7: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE III,
2022-2028 (IN $ MILLION)
FIGURE
8: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE IV, 2022-2028
(IN $ MILLION)
FIGURE
9: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2021 &
2028 (IN %)
FIGURE
10: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY CLINICAL TRIAL
SITE MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE
11: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY ADMINISTRATIVE SERVICES,
2022-2028 (IN $ MILLION)
FIGURE
12: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT
RECRUITMENT MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE
13: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY REGULATORY
SERVICES, 2022-2028 (IN $ MILLION)
FIGURE
14: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY DATA MANAGEMENT,
2022-2028 (IN $ MILLION)
FIGURE
15: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SERVICES,
2022-2028 (IN $ MILLION)
FIGURE
16: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2021
& 2028 (IN %)
FIGURE
17: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHARMACEUTICAL
& BIOPHARMACEUTICAL COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE
18: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY MEDICAL DEVICE
COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE
19: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SPONSORS,
2022-2028 (IN $ MILLION)
FIGURE
20: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021
& 2028 (IN %)
FIGURE
21: CHINA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
22: JAPAN CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
23: INDIA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
24: SOUTH KOREA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $
MILLION)
FIGURE
25: ASEAN COUNTRIES CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $
MILLION)
FIGURE
26: AUSTRALIA & NEW ZEALAND CLINICAL TRIALS SUPPORT SERVICES MARKET
2022-2028 (IN $ MILLION)
FIGURE
27: REST OF ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN
$ MILLION)